ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Chemical Regulation

Asbestos inhalation poses cancer risks to workers and consumers

US EPA finds unreasonable risks for 6 current uses, including chlor-alkali diaphragms

by Britt E. Erickson
March 31, 2020 | APPEARED IN VOLUME 98, ISSUE 13

 

09813-polcon4-sign.jpg
Credit: Shutterstock
The US EPA did not consider legacy uses, such as the presence of asbestos in construction materials in older buildings, in its latest draft risk evaluation.

The processing and use of asbestos-containing diaphragms by the chlor-alkali industry poses an unreasonable risk to the health of workers, the US Environmental Protection Agency concludes in a draft risk evaluation. The assessment, released March 30, also finds unreasonable risks to workers and consumers who process or use asbestos-containing sheet gaskets, brake blocks, aftermarket automotive brakes and linings, and other vehicle friction products and gaskets.

The EPA did not evaluate the risks of so-called legacy uses of asbestos, despite a November 2019 court order to do so. Legacy uses are when a substance is no longer used in a particular product, but those products, such as insulation and construction materials, still exist in older buildings. Experts estimate that the biggest source of exposure to asbestos for firefighters, workers, and the general public is from such legacy products made in the 1970s and earlier.

In the 2019 ruling, the court directed the EPA to consider legacy uses as well as the disposal of asbestos-containing products that are currently found in older buildings. The EPA says that it will evaluate such risks in a supplemental evaluation, but it did not specify when.

Inhalation of chrysotile, the most commonly used form of asbestos and the only form evaluated by the EPA, is associated with lung cancer and mesothelioma, a cancer of the linings of the lungs and other organs. Chrysotile is imported into the US in raw form, exclusively for the chlor-alkali industry, according to the EPA. In 2018, the US imported 750 metric tons of the raw substance, the agency says.

The chlor-alkali industry uses asbestos in semipermeable diaphragms that separate the two compartments of an electrolytic cell. The diaphragm prevents sodium hydroxide from reacting with chlorine and allows the two chemicals to be separated for further processing. Some chlor-alkali facilities use polymer ion-exchange membranes, such as Nafion membranes, as alternatives to asbestos diaphragms. Those membranes contain per- and polyfluoroalkyl substances, which have their own risks to human health and the environment.

The American Chemistry Council, which represents chemical manufacturers, claims that the EPA’s asbestos assessment overestimates exposure risks for certain chlor-alkali workers. “EPA bases its conclusion that there is an unreasonable risk of asbestos exposure to a subset of workers on invalid assumptions,” related to the use of personal protective equipment and other established safety protocols, the group says in a statement.

The EPA’s asbestos draft assessment is the ninth of the first 10 chemical risk evaluations that the agency is conducting under 2016 revisions to the Toxic Substances Control Act. The EPA faces a June deadline to finalize all 10 evaluations.

Advocacy groups, however, are urging the agency to delay external reviews of some assessments, including asbestos, because many reviewers are preoccupied with other responsibilities related to the COVID-19 pandemic.

“Many leading asbestos experts are medical doctors who are overwhelmed with supporting their colleagues and caring for patients as virus cases mount,” leaders of the Asbestos Disease Awareness Organization wrote in a March 30 letter to EPA Administrator Andrew Wheeler. “The asbestos risk evaluation is simply too important for EPA to proceed without the informed and thoughtful participation of leading asbestos experts.”

The EPA declined a request from environmental groups to postpone a March 24–27 virtual meeting of its external advisors to review the agency’s trichloroethylene draft assessment. It intends to hold an April 27–30 virtual meeting of the committee to discuss the asbestos evaluation.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment